ID   SHH_MOUSE               Reviewed;         437 AA.
AC   Q62226;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 2.
DT   24-JUN-2015, entry version 169.
DE   RecName: Full=Sonic hedgehog protein;
DE            Short=SHH;
DE   AltName: Full=HHG-1;
DE   Contains:
DE     RecName: Full=Sonic hedgehog protein N-product;
DE     AltName: Full=Sonic hedgehog protein 19 kDa product;
DE   Contains:
DE     RecName: Full=Sonic hedgehog protein C-product;
DE     AltName: Full=Sonic hedgehog protein 27 kDa product;
DE   Flags: Precursor;
GN   Name=Shh; Synonyms=Hhg1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Embryo;
RX   PubMed=7916661; DOI=10.1016/0092-8674(93)90627-3;
RA   Echelard Y., Epstein D.J., St Jacques B., Shen L., Mohler J.,
RA   McMahon J.A., McMahon A.P.;
RT   "Sonic hedgehog, a member of a family of putative signaling molecules,
RT   is implicated in the regulation of CNS polarity.";
RL   Cell 75:1417-1430(1993).
RN   [2]
RP   SEQUENCE REVISION TO 122.
RA   McMahon A.P.;
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEOLYTIC PROCESSING, AND AUTOCATALYTIC
RP   CLEAVAGE.
RX   PubMed=7720571;
RA   Chang D.T., Lopez A., von Kessler D.P., Chiang C., Simandl B.K.,
RA   Zhao R., Seldin M.F., Fallon J.F., Beachy P.A.;
RT   "Products, genetic linkage and limb patterning activity of a murine
RT   hedgehog gene.";
RL   Development 120:3339-3353(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Limb;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEOLYTIC PROCESSING, GLYCOSYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=7891723;
RA   Bumcrot D.A., Takada R., McMahon A.P.;
RT   "Proteolytic processing yields two secreted forms of sonic hedgehog.";
RL   Mol. Cell. Biol. 15:2294-2303(1995).
RN   [7]
RP   FUNCTION, PROTEOLYTIC PROCESSING, AND AUTOCATALYTIC CLEAVAGE.
RX   PubMed=7736596; DOI=10.1016/0092-8674(95)90397-6;
RA   Roelink H., Porter J.A., Chiang C., Tanabe Y., Chang D.T.,
RA   Beachy P.A., Jessell T.M.;
RT   "Floor plate and motor neuron induction by different concentrations of
RT   the amino-terminal cleavage product of sonic hedgehog
RT   autoproteolysis.";
RL   Cell 81:445-455(1995).
RN   [8]
RP   CHOLESTERYLATION AT GLY-198.
RX   PubMed=8824192; DOI=10.1126/science.274.5285.255;
RA   Porter J.A., Young K.E., Beachy P.A.;
RT   "Cholesterol modification of hedgehog signaling proteins in animal
RT   development.";
RL   Science 274:255-259(1996).
RN   [9]
RP   PALMITOYLATION AT CYS-25, AND MUTAGENESIS OF CYS-25.
RX   PubMed=11486055; DOI=10.1126/science.1064437;
RA   Chamoun Z., Mann R.K., Nellen D., von Kessler D.P., Bellotto M.,
RA   Beachy P.A., Basler K.;
RT   "Skinny hedgehog, an acyltransferase required for palmitoylation and
RT   activity of the hedgehog signal.";
RL   Science 293:2080-2084(2001).
RN   [10]
RP   FUNCTION IN CEREBELLAR DEVELOPMENT.
RX   PubMed=14687547; DOI=10.1016/S0896-6273(03)00769-4;
RA   Gold D.A., Baek S.H., Schork N.J., Rose D.W., Larsen D.D., Sachs B.D.,
RA   Rosenfeld M.G., Hamilton B.A.;
RT   "RORalpha coordinates reciprocal signaling in cerebellar development
RT   through sonic hedgehog and calcium-dependent pathways.";
RL   Neuron 40:1119-1131(2003).
RN   [11]
RP   PALMITOYLATION AT CYS-25, MUTAGENESIS OF CYS-25, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15075292; DOI=10.1101/gad.1185804;
RA   Chen M.-H., Li Y.-J., Kawakami T., Xu S.-M., Chuang P.-T.;
RT   "Palmitoylation is required for the production of a soluble multimeric
RT   Hedgehog protein complex and long-range signaling in vertebrates.";
RL   Genes Dev. 18:641-659(2004).
RN   [12]
RP   MUTAGENESIS OF GLY-32; ASP-89; GLN-101; ASN-116; TRP-118 AND GLU-189.
RX   PubMed=16282375; DOI=10.1073/pnas.0507848102;
RA   Maity T., Fuse N., Beachy P.A.;
RT   "Molecular mechanisms of Sonic hedgehog mutant effects in
RT   holoprosencephaly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:17026-17031(2005).
RN   [13]
RP   INTERACTION WITH HHATL.
RX   PubMed=18081866; DOI=10.1111/j.1742-4658.2007.06202.x;
RA   Abe Y., Kita Y., Niikura T.;
RT   "Mammalian Gup1, a homolog of Saccharomyces cerevisiae glycerol
RT   uptake/transporter 1, acts as a negative regulator for N-terminal
RT   palmitoylation of Sonic hedgehog.";
RL   FEBS J. 275:318-331(2008).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 34-195 IN COMPLEX WITH ZINC
RP   IONS.
RX   PubMed=7477329; DOI=10.1038/378212a0;
RA   Hall T.M.T., Porter J.A., Beachy P.A., Leahy D.J.;
RT   "A potential catalytic site revealed by the 1.7-A crystal structure of
RT   the amino-terminal signalling domain of Sonic hedgehog.";
RL   Nature 378:212-216(1995).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 26-189 IN COMPLEX WITH CDON;
RP   CALCIUM AND ZINC IONS, DOMAIN, AND INTERACTION WITH CDON.
RX   PubMed=18794898; DOI=10.1038/nature07358;
RA   McLellan J.S., Zheng X., Hauk G., Ghirlando R., Beachy P.A.,
RA   Leahy D.J.;
RT   "The mode of Hedgehog binding to Ihog homologues is not conserved
RT   across different phyla.";
RL   Nature 455:979-983(2008).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 40-191 IN COMPLEX WITH HHIP;
RP   CALCIUM AND ZINC IONS, DOMAIN, AND INTERACTION WITH HHIP.
RX   PubMed=19561611; DOI=10.1038/nsmb.1607;
RA   Bishop B., Aricescu A.R., Harlos K., O'Callaghan C.A., Jones E.Y.,
RA   Siebold C.;
RT   "Structural insights into hedgehog ligand sequestration by the human
RT   hedgehog-interacting protein HHIP.";
RL   Nat. Struct. Mol. Biol. 16:698-703(2009).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 26-189 IN COMPLEX WITH
RP   CALCIUM AND ZINC IONS, DOMAIN, AND INTERACTION WITH BOC AND CDON.
RX   PubMed=20519495; DOI=10.1074/jbc.M110.131680;
RA   Kavran J.M., Ward M.D., Oladosu O.O., Mulepati S., Leahy D.J.;
RT   "All mammalian Hedgehog proteins interact with cell adhesion molecule,
RT   down-regulated by oncogenes (CDO) and brother of CDO (BOC) in a
RT   conserved manner.";
RL   J. Biol. Chem. 285:24584-24590(2010).
CC   -!- FUNCTION: Intercellular signal essential for a variety of
CC       patterning events during development: signal produced by the
CC       notochord that induces ventral cell fate in the neural tube and
CC       somites, and the polarizing signal for patterning of the anterior-
CC       posterior axis of the developing limb bud. Displays both floor
CC       plate- and motor neuron-inducing activity. The threshold
CC       concentration of N-product required for motor neuron induction is
CC       5-fold lower than that required for floor plate induction.
CC       Activates the transcription of target genes by interacting with
CC       its receptor PTCH1 to prevent normal inhibition by PTCH1 on the
CC       constitutive signaling activity of SMO.
CC       {ECO:0000269|PubMed:14687547, ECO:0000269|PubMed:7736596}.
CC   -!- SUBUNIT: Interacts with HHATL/GUP1 which negatively regulates
CC       HHAT-mediated palmitoylation of the SHH N-terminus. N-product is
CC       active as a multimer. Interacts with BOC and CDON. Interacts with
CC       HHIP. {ECO:0000269|PubMed:15075292, ECO:0000269|PubMed:18081866,
CC       ECO:0000269|PubMed:18794898, ECO:0000269|PubMed:19561611,
CC       ECO:0000269|PubMed:20519495, ECO:0000269|PubMed:7477329}.
CC   -!- SUBCELLULAR LOCATION: Sonic hedgehog protein C-product: Secreted,
CC       extracellular space. Note=The C-terminal peptide diffuses from the
CC       cell.
CC   -!- SUBCELLULAR LOCATION: Sonic hedgehog protein N-product: Cell
CC       membrane; Lipid-anchor. Note=The N-product either remains
CC       associated with lipid rafts at the cell surface, or forms freely
CC       diffusible active multimers with its hydrophobic lipid-modified N-
CC       and C-termini buried inside.
CC   -!- TISSUE SPECIFICITY: Expressed in a number of embryonic tissues
CC       including the notochord, ventral neural tube, floor plate, lung
CC       bud, zone of polarizing activity and posterior distal mesenchyme
CC       of limbs. In the adult, expressed in lung and neural retina.
CC   -!- DEVELOPMENTAL STAGE: First detectable during gastrulation.
CC   -!- INDUCTION: By retinoic acid.
CC   -!- DOMAIN: The sonic hedgehog protein N-product binds calcium and
CC       zinc ions; this stabilizes the protein fold and is essential for
CC       protein-protein interactions mediated by this domain.
CC       {ECO:0000269|PubMed:18794898, ECO:0000269|PubMed:19561611,
CC       ECO:0000269|PubMed:20519495}.
CC   -!- PTM: The C-terminal domain displays an autoproteolysis activity
CC       and a cholesterol transferase activity. Both activities result in
CC       the cleavage of the full-length protein and covalent attachment of
CC       a cholesterol moiety to the C-terminal of the newly generated N-
CC       terminal fragment (N-product). The N-product is the active species
CC       in both local and long-range signaling, whereas the C-product has
CC       no signaling activity. {ECO:0000269|PubMed:7720571,
CC       ECO:0000269|PubMed:7736596, ECO:0000269|PubMed:7891723}.
CC   -!- PTM: Cholesterylation is required for N-product targeting to lipid
CC       rafts and multimerization. {ECO:0000269|PubMed:8824192}.
CC   -!- PTM: N-palmitoylation of Cys-25 by HHAT is required for N-product
CC       multimerization and full activity. {ECO:0000269|PubMed:11486055,
CC       ECO:0000269|PubMed:15075292}.
CC   -!- MISCELLANEOUS: Mice overexpressing Shh display digit duplications
CC       in both forelimbs and hindlimbs.
CC   -!- SIMILARITY: Belongs to the hedgehog family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X76290; CAA53922.1; -; mRNA.
DR   EMBL; AK077688; BAC36956.1; -; mRNA.
DR   EMBL; BC063087; AAH63087.1; -; mRNA.
DR   CCDS; CCDS19146.1; -.
DR   PIR; A49425; A49425.
DR   RefSeq; NP_033196.1; NM_009170.3.
DR   UniGene; Mm.57202; -.
DR   PDB; 1VHH; X-ray; 1.70 A; A=34-195.
DR   PDB; 2WFX; X-ray; 3.20 A; A=40-191.
DR   PDB; 2WG4; X-ray; 3.15 A; A=40-191.
DR   PDB; 3D1M; X-ray; 1.70 A; A/B=26-189.
DR   PDB; 3N1R; X-ray; 2.13 A; A=40-195.
DR   PDB; 4C4M; X-ray; 1.74 A; A=40-195.
DR   PDB; 4C4N; X-ray; 2.36 A; A/B=40-195.
DR   PDBsum; 1VHH; -.
DR   PDBsum; 2WFX; -.
DR   PDBsum; 2WG4; -.
DR   PDBsum; 3D1M; -.
DR   PDBsum; 3N1R; -.
DR   PDBsum; 4C4M; -.
DR   PDBsum; 4C4N; -.
DR   ProteinModelPortal; Q62226; -.
DR   SMR; Q62226; 39-195, 199-351.
DR   BioGrid; 203220; 10.
DR   DIP; DIP-48537N; -.
DR   STRING; 10090.ENSMUSP00000002708; -.
DR   BindingDB; Q62226; -.
DR   ChEMBL; CHEMBL5387; -.
DR   MEROPS; C46.002; -.
DR   PhosphoSite; Q62226; -.
DR   PRIDE; Q62226; -.
DR   Ensembl; ENSMUST00000002708; ENSMUSP00000002708; ENSMUSG00000002633.
DR   GeneID; 20423; -.
DR   KEGG; mmu:20423; -.
DR   UCSC; uc008wua.2; mouse.
DR   CTD; 6469; -.
DR   MGI; MGI:98297; Shh.
DR   eggNOG; NOG250647; -.
DR   GeneTree; ENSGT00390000001117; -.
DR   HOGENOM; HOG000233428; -.
DR   HOVERGEN; HBG005480; -.
DR   InParanoid; Q62226; -.
DR   KO; K11988; -.
DR   OMA; HSWAHRA; -.
DR   OrthoDB; EOG779NZ5; -.
DR   PhylomeDB; Q62226; -.
DR   TreeFam; TF106458; -.
DR   Reactome; REACT_282161; Release of Hh-Np from the secreting cell.
DR   Reactome; REACT_295321; Ligand-receptor interactions.
DR   Reactome; REACT_335449; Class B/2 (Secretin family receptors).
DR   Reactome; REACT_347264; Hedgehog ligand biogenesis.
DR   EvolutionaryTrace; Q62226; -.
DR   NextBio; 298432; -.
DR   PRO; PR:Q62226; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   Bgee; Q62226; -.
DR   CleanEx; MM_SHH; -.
DR   Genevisible; Q62226; MM.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:MGI.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0045121; C:membrane raft; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IDA:MGI.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0001948; F:glycoprotein binding; IDA:MGI.
DR   GO; GO:0005539; F:glycosaminoglycan binding; IDA:MGI.
DR   GO; GO:0043237; F:laminin-1 binding; IDA:MGI.
DR   GO; GO:0005113; F:patched binding; IPI:Roslin.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0048856; P:anatomical structure development; IMP:MGI.
DR   GO; GO:0048646; P:anatomical structure formation involved in morphogenesis; IMP:MGI.
DR   GO; GO:0008209; P:androgen metabolic process; IMP:MGI.
DR   GO; GO:0001525; P:angiogenesis; IDA:MGI.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IMP:MGI.
DR   GO; GO:0006915; P:apoptotic process; IGI:MGI.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IDA:Roslin.
DR   GO; GO:0060840; P:artery development; IMP:MGI.
DR   GO; GO:0007411; P:axon guidance; IDA:MGI.
DR   GO; GO:0060020; P:Bergmann glial cell differentiation; IDA:MGI.
DR   GO; GO:0007596; P:blood coagulation; IMP:MGI.
DR   GO; GO:0060442; P:branching involved in prostate gland morphogenesis; IDA:MGI.
DR   GO; GO:0060445; P:branching involved in salivary gland morphogenesis; IMP:MGI.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IMP:MGI.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IMP:MGI.
DR   GO; GO:0060447; P:bud outgrowth involved in lung branching; IMP:MGI.
DR   GO; GO:0043010; P:camera-type eye development; IDA:MGI.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IDA:MGI.
DR   GO; GO:0043369; P:CD4-positive or CD8-positive, alpha-beta T cell lineage commitment; IMP:BHF-UCL.
DR   GO; GO:0048468; P:cell development; IMP:MGI.
DR   GO; GO:0045165; P:cell fate commitment; IGI:MGI.
DR   GO; GO:0001708; P:cell fate specification; IDA:MGI.
DR   GO; GO:0008283; P:cell proliferation; IGI:MGI.
DR   GO; GO:0007267; P:cell-cell signaling; IMP:MGI.
DR   GO; GO:0071285; P:cellular response to lithium ion; IDA:MGI.
DR   GO; GO:0007417; P:central nervous system development; IMP:MGI.
DR   GO; GO:0021930; P:cerebellar granule cell precursor proliferation; IGI:UniProtKB.
DR   GO; GO:0003140; P:determination of left/right asymmetry in lateral mesoderm; IMP:BHF-UCL.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:MGI.
DR   GO; GO:0048589; P:developmental growth; IMP:MGI.
DR   GO; GO:0048546; P:digestive tract morphogenesis; IMP:MGI.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; IMP:BHF-UCL.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IGI:MGI.
DR   GO; GO:0007398; P:ectoderm development; IMP:MGI.
DR   GO; GO:0048557; P:embryonic digestive tract morphogenesis; TAS:BHF-UCL.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IMP:Roslin.
DR   GO; GO:0048617; P:embryonic foregut morphogenesis; IMP:MGI.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IMP:MGI.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IMP:MGI.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IMP:MGI.
DR   GO; GO:0048598; P:embryonic morphogenesis; IMP:MGI.
DR   GO; GO:0048568; P:embryonic organ development; IMP:MGI.
DR   GO; GO:0048706; P:embryonic skeletal system development; IGI:MGI.
DR   GO; GO:0006897; P:endocytosis; IDA:MGI.
DR   GO; GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IMP:MGI.
DR   GO; GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IMP:MGI.
DR   GO; GO:0060684; P:epithelial-mesenchymal cell signaling; IMP:MGI.
DR   GO; GO:0060738; P:epithelial-mesenchymal signaling involved in prostate gland development; IGI:MGI.
DR   GO; GO:0030010; P:establishment of cell polarity; IDA:MGI.
DR   GO; GO:0030900; P:forebrain development; IGI:MGI.
DR   GO; GO:0048859; P:formation of anatomical boundary; IMP:MGI.
DR   GO; GO:0001942; P:hair follicle development; IMP:MGI.
DR   GO; GO:0031069; P:hair follicle morphogenesis; IMP:MGI.
DR   GO; GO:0007507; P:heart development; IMP:MGI.
DR   GO; GO:0001947; P:heart looping; IMP:BHF-UCL.
DR   GO; GO:0030902; P:hindbrain development; IMP:MGI.
DR   GO; GO:0007442; P:hindgut morphogenesis; IMP:MGI.
DR   GO; GO:0048839; P:inner ear development; IMP:MGI.
DR   GO; GO:0016539; P:intein-mediated protein splicing; IEA:InterPro.
DR   GO; GO:0045109; P:intermediate filament organization; IMP:MGI.
DR   GO; GO:0001822; P:kidney development; IMP:MGI.
DR   GO; GO:0060459; P:left lung development; IMP:MGI.
DR   GO; GO:0060174; P:limb bud formation; IMP:MGI.
DR   GO; GO:0060173; P:limb development; IMP:MGI.
DR   GO; GO:0030324; P:lung development; IMP:MGI.
DR   GO; GO:0060428; P:lung epithelium development; IMP:MGI.
DR   GO; GO:0060463; P:lung lobe morphogenesis; IMP:MGI.
DR   GO; GO:0060425; P:lung morphogenesis; IMP:MGI.
DR   GO; GO:0060484; P:lung-associated mesenchyme development; IMP:MGI.
DR   GO; GO:0002320; P:lymphoid progenitor cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0030539; P:male genitalia development; IMP:MGI.
DR   GO; GO:0010463; P:mesenchymal cell proliferation; IMP:MGI.
DR   GO; GO:0060916; P:mesenchymal cell proliferation involved in lung development; IDA:MGI.
DR   GO; GO:0060783; P:mesenchymal smoothened signaling pathway involved in prostate gland development; IMP:MGI.
DR   GO; GO:0072136; P:metanephric mesenchymal cell proliferation involved in metanephros development; IMP:UniProtKB.
DR   GO; GO:0001656; P:metanephros development; IMP:UniProtKB.
DR   GO; GO:0030901; P:midbrain development; IGI:MGI.
DR   GO; GO:0080125; P:multicellular structure septum development; IMP:MGI.
DR   GO; GO:0045445; P:myoblast differentiation; IDA:MGI.
DR   GO; GO:0014902; P:myotube differentiation; IMP:MGI.
DR   GO; GO:0046639; P:negative regulation of alpha-beta T cell differentiation; IMP:MGI.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:Roslin.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:MGI.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; IDA:MGI.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:MGI.
DR   GO; GO:0090370; P:negative regulation of cholesterol efflux; IMP:BHF-UCL.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:2000357; P:negative regulation of kidney smooth muscle cell differentiation; IDA:UniProtKB.
DR   GO; GO:2001054; P:negative regulation of mesenchymal cell apoptotic process; IMP:MGI.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:MGI.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; IMP:MGI.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IMP:MGI.
DR   GO; GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IDA:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:2000062; P:negative regulation of ureter smooth muscle cell differentiation; IDA:UniProtKB.
DR   GO; GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:MGI.
DR   GO; GO:0045060; P:negative thymic T cell selection; IMP:BHF-UCL.
DR   GO; GO:0001755; P:neural crest cell migration; IMP:MGI.
DR   GO; GO:0007405; P:neuroblast proliferation; IDA:MGI.
DR   GO; GO:0048663; P:neuron fate commitment; IMP:MGI.
DR   GO; GO:0042476; P:odontogenesis; IDA:MGI.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IMP:MGI.
DR   GO; GO:0014003; P:oligodendrocyte development; IDA:MGI.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IGI:MGI.
DR   GO; GO:0048645; P:organ formation; IMP:MGI.
DR   GO; GO:0002076; P:osteoblast development; IDA:MGI.
DR   GO; GO:0060021; P:palate development; IMP:MGI.
DR   GO; GO:0031016; P:pancreas development; IMP:MGI.
DR   GO; GO:0007389; P:pattern specification process; IMP:MGI.
DR   GO; GO:0001569; P:patterning of blood vessels; IMP:MGI.
DR   GO; GO:0009949; P:polarity specification of anterior/posterior axis; IMP:Roslin.
DR   GO; GO:0046638; P:positive regulation of alpha-beta T cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IMP:MGI.
DR   GO; GO:0051781; P:positive regulation of cell division; ISO:MGI.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:MGI.
DR   GO; GO:0021940; P:positive regulation of cerebellar granule cell precursor proliferation; IDA:MGI.
DR   GO; GO:0060769; P:positive regulation of epithelial cell proliferation involved in prostate gland development; IMP:MGI.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0007228; P:positive regulation of hh target transcription factor activity; IMP:BHF-UCL.
DR   GO; GO:0033092; P:positive regulation of immature T cell proliferation in thymus; IMP:BHF-UCL.
DR   GO; GO:2000358; P:positive regulation of kidney smooth muscle cell differentiation; IDA:UniProtKB.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; IMP:MGI.
DR   GO; GO:2000729; P:positive regulation of mesenchymal cell proliferation involved in ureter development; IMP:UniProtKB.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; IDA:MGI.
DR   GO; GO:0048714; P:positive regulation of oligodendrocyte differentiation; IDA:MGI.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; IGI:MGI.
DR   GO; GO:0061189; P:positive regulation of sclerotome development; ISO:MGI.
DR   GO; GO:0014858; P:positive regulation of skeletal muscle cell proliferation; IMP:MGI.
DR   GO; GO:0048643; P:positive regulation of skeletal muscle tissue development; IMP:MGI.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; ISS:UniProtKB.
DR   GO; GO:0051155; P:positive regulation of striated muscle cell differentiation; IMP:MGI.
DR   GO; GO:0033089; P:positive regulation of T cell differentiation in thymus; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:2000063; P:positive regulation of ureter smooth muscle cell differentiation; IMP:UniProtKB.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; IMP:MGI.
DR   GO; GO:0045059; P:positive thymic T cell selection; IMP:BHF-UCL.
DR   GO; GO:0060516; P:primary prostatic bud elongation; IDA:MGI.
DR   GO; GO:0060523; P:prostate epithelial cord elongation; IDA:MGI.
DR   GO; GO:0030850; P:prostate gland development; IMP:MGI.
DR   GO; GO:0034504; P:protein localization to nucleus; IDA:MGI.
DR   GO; GO:0042127; P:regulation of cell proliferation; IDA:MGI.
DR   GO; GO:0060768; P:regulation of epithelial cell proliferation involved in prostate gland development; IMP:MGI.
DR   GO; GO:0010468; P:regulation of gene expression; IDA:MGI.
DR   GO; GO:0060782; P:regulation of mesenchymal cell proliferation involved in prostate gland development; IMP:MGI.
DR   GO; GO:0042481; P:regulation of odontogenesis; IMP:BHF-UCL.
DR   GO; GO:0060685; P:regulation of prostatic bud formation; IDA:MGI.
DR   GO; GO:1900180; P:regulation of protein localization to nucleus; ISO:MGI.
DR   GO; GO:0030162; P:regulation of proteolysis; IDA:MGI.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IMP:MGI.
DR   GO; GO:0030323; P:respiratory tube development; IMP:MGI.
DR   GO; GO:0060458; P:right lung development; IMP:MGI.
DR   GO; GO:0060662; P:salivary gland cavitation; IDA:MGI.
DR   GO; GO:0007165; P:signal transduction; TAS:MGI.
DR   GO; GO:0043588; P:skin development; IMP:MGI.
DR   GO; GO:0007224; P:smoothened signaling pathway; IDA:MGI.
DR   GO; GO:0021938; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; IDA:MGI.
DR   GO; GO:0061053; P:somite development; IMP:BHF-UCL.
DR   GO; GO:0021513; P:spinal cord dorsal/ventral patterning; IMP:MGI.
DR   GO; GO:0021522; P:spinal cord motor neuron differentiation; IGI:MGI.
DR   GO; GO:0048864; P:stem cell development; IMP:BHF-UCL.
DR   GO; GO:0051146; P:striated muscle cell differentiation; IDA:MGI.
DR   GO; GO:0014706; P:striated muscle tissue development; IMP:MGI.
DR   GO; GO:0033077; P:T cell differentiation in thymus; IMP:BHF-UCL.
DR   GO; GO:0021978; P:telencephalon regionalization; IMP:MGI.
DR   GO; GO:0021794; P:thalamus development; IMP:MGI.
DR   GO; GO:0048538; P:thymus development; IMP:BHF-UCL.
DR   GO; GO:0030878; P:thyroid gland development; IMP:MGI.
DR   GO; GO:0060438; P:trachea development; IMP:MGI.
DR   GO; GO:0060439; P:trachea morphogenesis; IMP:MGI.
DR   GO; GO:0001944; P:vasculature development; IMP:MGI.
DR   GO; GO:0001570; P:vasculogenesis; IDA:MGI.
DR   GO; GO:0060979; P:vasculogenesis involved in coronary vascular morphogenesis; TAS:DFLAT.
DR   GO; GO:0021521; P:ventral spinal cord interneuron specification; ISO:MGI.
DR   Gene3D; 2.170.16.10; -; 1.
DR   Gene3D; 3.30.1380.10; -; 1.
DR   InterPro; IPR001657; Hedgehog.
DR   InterPro; IPR028992; Hedgehog/Intein_dom.
DR   InterPro; IPR009045; Hedgehog_sig/DD-Pept_Zn-bd_dom.
DR   InterPro; IPR000320; Hedgehog_signalling_dom.
DR   InterPro; IPR001767; Hint_dom.
DR   InterPro; IPR003586; Hint_dom_C.
DR   InterPro; IPR003587; Hint_dom_N.
DR   InterPro; IPR006141; Intein_N.
DR   Pfam; PF01085; HH_signal; 1.
DR   Pfam; PF01079; Hint; 1.
DR   PIRSF; PIRSF009400; Peptidase_C46; 1.
DR   PRINTS; PR00632; SONICHHOG.
DR   SMART; SM00305; HintC; 1.
DR   SMART; SM00306; HintN; 1.
DR   SUPFAM; SSF51294; SSF51294; 1.
DR   SUPFAM; SSF55166; SSF55166; 1.
DR   PROSITE; PS50817; INTEIN_N_TER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Autocatalytic cleavage; Calcium; Cell membrane;
KW   Complete proteome; Developmental protein; Glycoprotein; Hydrolase;
KW   Lipoprotein; Membrane; Metal-binding; Palmitate; Protease;
KW   Reference proteome; Secreted; Signal; Zinc.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    437       Sonic hedgehog protein.
FT                                /FTId=PRO_0000013211.
FT   CHAIN        25    198       Sonic hedgehog protein N-product.
FT                                /FTId=PRO_0000013212.
FT   CHAIN       199    437       Sonic hedgehog protein C-product.
FT                                /FTId=PRO_0000013213.
FT   COMPBIAS    383    387       Poly-Gly.
FT   METAL        90     90       Calcium 1. {ECO:0000269|PubMed:18794898,
FT                                ECO:0000269|PubMed:19561611,
FT                                ECO:0000269|PubMed:20519495}.
FT   METAL        91     91       Calcium 1. {ECO:0000269|PubMed:18794898,
FT                                ECO:0000269|PubMed:19561611,
FT                                ECO:0000269|PubMed:20519495}.
FT   METAL        91     91       Calcium 2. {ECO:0000269|PubMed:18794898,
FT                                ECO:0000269|PubMed:19561611,
FT                                ECO:0000269|PubMed:20519495}.
FT   METAL        96     96       Calcium 1. {ECO:0000269|PubMed:18794898,
FT                                ECO:0000269|PubMed:19561611,
FT                                ECO:0000269|PubMed:20519495}.
FT   METAL       126    126       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:18794898,
FT                                ECO:0000269|PubMed:19561611,
FT                                ECO:0000269|PubMed:20519495}.
FT   METAL       127    127       Calcium 1. {ECO:0000269|PubMed:18794898,
FT                                ECO:0000269|PubMed:19561611,
FT                                ECO:0000269|PubMed:20519495}.
FT   METAL       127    127       Calcium 2. {ECO:0000269|PubMed:18794898,
FT                                ECO:0000269|PubMed:19561611,
FT                                ECO:0000269|PubMed:20519495}.
FT   METAL       130    130       Calcium 2. {ECO:0000269|PubMed:18794898,
FT                                ECO:0000269|PubMed:19561611,
FT                                ECO:0000269|PubMed:20519495}.
FT   METAL       132    132       Calcium 2. {ECO:0000269|PubMed:18794898,
FT                                ECO:0000269|PubMed:19561611,
FT                                ECO:0000269|PubMed:20519495}.
FT   METAL       141    141       Zinc.
FT   METAL       148    148       Zinc.
FT   METAL       183    183       Zinc.
FT   SITE        198    199       Cleavage; by autolysis. {ECO:0000250}.
FT   SITE        244    244       Involved in cholesterol transfer.
FT                                {ECO:0000250}.
FT   SITE        268    268       Involved in auto-cleavage. {ECO:0000250}.
FT   SITE        271    271       Essential for auto-cleavage.
FT                                {ECO:0000250}.
FT   LIPID        25     25       N-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:11486055,
FT                                ECO:0000269|PubMed:15075292}.
FT   LIPID       198    198       Cholesterol glycine ester.
FT                                {ECO:0000269|PubMed:8824192}.
FT   CARBOHYD    279    279       N-linked (GlcNAc...). {ECO:0000255}.
FT   MUTAGEN      25     25       C->S: Strongly reduces effects of in vivo
FT                                overexpression; impairs multimer
FT                                formation; does not affect subcellular
FT                                location to lipid rafts. Homozygous mice
FT                                are characterized by a smaller size and
FT                                holoprosencephaly at E10.5, and
FT                                shortening of limbs at E13.5. They die
FT                                soon after birth.
FT                                {ECO:0000269|PubMed:11486055,
FT                                ECO:0000269|PubMed:15075292}.
FT   MUTAGEN      32     32       G->R: Introduces a cleavage site for a
FT                                furin-like protease resulting in abnormal
FT                                protein processing; cleavage at this site
FT                                removes 11 amino acids from the N-
FT                                terminal domain and reduces affinity of
FT                                Shh for Ptch1 and signaling potency in
FT                                assays using chicken embryo neural plate
FT                                explants and mouse C3H10T1/2 stem cells.
FT                                {ECO:0000269|PubMed:16282375}.
FT   MUTAGEN      89     89       D->V: Moderately reduces Ptch1 binding in
FT                                vitro and signaling potency in chicken
FT                                embryo neural plate explant assays
FT                                compared with wild-type sequence.
FT                                {ECO:0000269|PubMed:16282375}.
FT   MUTAGEN     101    101       Q->H: Does not affect signaling activity
FT                                in any of Shh signaling assays and causes
FT                                no apparent defects in cholesterol-
FT                                mediated autoprocessing reactions.
FT                                {ECO:0000269|PubMed:16282375}.
FT   MUTAGEN     116    116       N->K: Shows no change in activities at
FT                                different temperatures.
FT                                {ECO:0000269|PubMed:16282375}.
FT   MUTAGEN     118    118       W->G: Causes a failure of Shh processing
FT                                leading to retention of the immature
FT                                glycosylated protein within the
FT                                endoplasmic reticulum of transfected
FT                                cells; causes a temperature-dependent
FT                                conformational change that allows Shh to
FT                                bind Ptch1 at 4 or 32 degrees Celsius but
FT                                not at 37 degrees Celsius; drastically
FT                                reduces signaling potency in chicken
FT                                embryo neural plate explant assays.
FT                                {ECO:0000269|PubMed:16282375}.
FT   MUTAGEN     118    118       W->R: Causes a failure of Shh processing
FT                                leading to retention of the immature
FT                                glycosylated protein within the
FT                                endoplasmic reticulum of transfected
FT                                cells; causes a temperature-dependent
FT                                conformational change that allows Shh to
FT                                bind Ptch1 at 4 or 32 degrees Celsius but
FT                                not at 37 degrees Celsius; drastically
FT                                reduces signaling potency in chicken
FT                                embryo neural plate explant assays.
FT                                {ECO:0000269|PubMed:16282375}.
FT   MUTAGEN     189    189       E->Q: Does not affect signaling activity
FT                                in any of Shh signaling assays and causes
FT                                no apparent defects in cholesterol-
FT                                mediated autoprocessing reactions.
FT                                {ECO:0000269|PubMed:16282375}.
FT   STRAND       48     52       {ECO:0000244|PDB:1VHH}.
FT   TURN         57     60       {ECO:0000244|PDB:1VHH}.
FT   STRAND       69     71       {ECO:0000244|PDB:3N1R}.
FT   HELIX        72     76       {ECO:0000244|PDB:1VHH}.
FT   STRAND       85     87       {ECO:0000244|PDB:1VHH}.
FT   STRAND       92     94       {ECO:0000244|PDB:1VHH}.
FT   HELIX        95     97       {ECO:0000244|PDB:1VHH}.
FT   HELIX       101    117       {ECO:0000244|PDB:1VHH}.
FT   STRAND      123    127       {ECO:0000244|PDB:1VHH}.
FT   STRAND      131    135       {ECO:0000244|PDB:2WG4}.
FT   HELIX       140    143       {ECO:0000244|PDB:1VHH}.
FT   STRAND      146    151       {ECO:0000244|PDB:1VHH}.
FT   HELIX       156    158       {ECO:0000244|PDB:1VHH}.
FT   HELIX       159    168       {ECO:0000244|PDB:1VHH}.
FT   STRAND      172    178       {ECO:0000244|PDB:1VHH}.
FT   STRAND      181    185       {ECO:0000244|PDB:1VHH}.
FT   HELIX       189    192       {ECO:0000244|PDB:1VHH}.
SQ   SEQUENCE   437 AA;  47773 MW;  D0EB72F08E7860EF CRC64;
     MLLLLARCFL VILASSLLVC PGLACGPGRG FGKRRHPKKL TPLAYKQFIP NVAEKTLGAS
     GRYEGKITRN SERFKELTPN YNPDIIFKDE ENTGADRLMT QRCKDKLNAL AISVMNQWPG
     VKLRVTEGWD EDGHHSEESL HYEGRAVDIT TSDRDRSKYG MLARLAVEAG FDWVYYESKA
     HIHCSVKAEN SVAAKSGGCF PGSATVHLEQ GGTKLVKDLR PGDRVLAADD QGRLLYSDFL
     TFLDRDEGAK KVFYVIETLE PRERLLLTAA HLLFVAPHND SGPTPGPSAL FASRVRPGQR
     VYVVAERGGD RRLLPAAVHS VTLREEEAGA YAPLTAHGTI LINRVLASCY AVIEEHSWAH
     RAFAPFRLAH ALLAALAPAR TDGGGGGSIP AAQSATEARG AEPTAGIHWY SQLLYHIGTW
     LLDSETMHPL GMAVKSS
//
